Cannabis in the United Kingdom

The UK cannabis market presents a mixed picture in 2024. Medical cannabis maintains its momentum, with value growth still in high double digits and another significant rise in patient numbers. Nevertheless, cost and accessibility issues continue to hamper uptake of medical cannabis, which is heavily skewed towards private channels rather than the public healthcare system, the NHS.

The Cannabis in United Kingdom market report offers a comprehensive guide to the size and shape of this emerging market opportunity at a national level. It provides the latest retail sales data (historic date range), allowing you to identify the key cannabinoid categories driving growth. It outlines the regulatory, cultural and commercial context and offers strategic analysis of key factors influencing the market - legislative developments both current and future, economic/lifestyle influences, illicit consumption, product innovation, distribution and pricing trends. Forecasts to 2029 illustrate how the market is set to expand and change.

Product coverage: Adult-Use Cannabis, CBD & Other Non-Intoxicating Cannabinoids, Medical Cannabis.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Cannabis market
• Pinpoint growth sectors and identify factors driving change
• Understand the competitive environment, the market’s major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop.